Aspiration and injection procedure to treat a bone cyst — fluid is drawn out and a therapeutic agent is injected to promote healing.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $249.50
- Total RVUs
- 7.47
- Global, days
- 10
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Pre-procedure imaging (X-ray, CT, or MRI) documenting cyst location, size, and bone integrity
- Specific bone and anatomic site of the cyst — not just 'long bone' or 'extremity'
- Imaging guidance modality used during the procedure (fluoroscopy, ultrasound), if applicable
- Identity and volume of the injected therapeutic agent (corticosteroid, bone-hardening agent, etc.)
- Volume and character of fluid aspirated from the cyst
- Laterality — left, right, or bilateral — documented explicitly in the procedure note
- Medical necessity narrative: prior conservative management, fracture risk, or failed prior aspiration
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 20615 covers nonsurgical, percutaneous treatment of a bone cyst: the cyst is aspirated to remove fluid, then a therapeutic substance — corticosteroid, bone-hardening agent, or similar material — is injected to promote healing and reduce recurrence risk. The procedure is typically performed under imaging guidance (fluoroscopy or ultrasound) and is classified under General Introduction or Removal Procedures on the Musculoskeletal System. It carries a 10-day global period, meaning any related E/M visits within that window require modifier 24 to bill separately.
Bone cysts most commonly occur in the metaphysis of long bones and are most frequently treated in pediatric or adolescent patients, though adults present as well. Pre-procedure imaging — X-ray, CT, or MRI — must document cyst location, size, and structural integrity of the surrounding bone. Operative or procedure notes must specify the imaging guidance used, the substance injected, and the volume aspirated. If fluoroscopic guidance is separately reportable, check NCCI edits before stacking guidance codes with 20615.
Site of service matters here. The HOPD and ASC payment rates differ substantially (see the Site of Service comparison table). Office-based performance (POS 11) is common and carries its own RVU-driven reimbursement. If the procedure is performed bilaterally — cysts on corresponding bones on each side — append modifier 50 and document both sites explicitly in the procedure note.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 2.27 |
| Practice expense RVU | 4.95 |
| Malpractice RVU | 0.25 |
| Total RVU | 7.47 |
| Medicare national rate | $249.50 |
| Global period | 10 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $249.50 |
HOPD (APC 5071) Hospital outpatient department | $723.47 |
ASC (PI P3) Ambulatory surgical center (freestanding) | $166.16 |
Common denial reasons
The recurring reasons claims for CPT 20615 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Missing pre-procedure imaging to establish medical necessity and cyst diagnosis
- Bundling conflict when imaging guidance codes are billed alongside 20615 without verifying NCCI edits
- Laterality modifier absent when procedure is performed on a paired bone — payer edits flag unlateralized claims
- Insufficient documentation of the injected substance — claims denied when operative note omits agent identity or volume
- Repeat procedure billed without modifier 76 (same physician) or 77 (different physician), triggering duplicate claim edits
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01Can imaging guidance be billed separately with 20615?
02What modifier do I use when the same physician repeats the aspiration and injection on the same day?
03Is 20615 bilateral-billable, and how should I report it?
04What global period applies to 20615, and what does that mean for post-procedure E/M visits?
05What ICD-10 codes typically support medical necessity for 20615?
06Can 20615 be billed in an office setting, or is it restricted to hospital outpatient or ASC?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02aapc.comhttps://www.aapc.com/codes/cpt-codes/20615
- 03bedrockbilling.comhttps://bedrockbilling.com/static/cci/20615
- 04payerprice.comhttps://payerprice.com/rates/20615-CPT-fee-schedule
- 05emedny.orghttps://www.emedny.org/providermanuals/physician/pdfs/physician%20procedure%20codes%20sect5.pdf
- 06genhealth.aihttps://genhealth.ai/code/cpt4/20615-aspiration-and-injection-for-treatment-of-bone-cyst
Mira AI Scribe
Mira's AI scribe captures the cyst location by named bone and anatomic region, laterality, imaging guidance modality, the therapeutic agent injected with volume, and the character and volume of aspirated fluid — all from dictation. That prevents the two most common denial triggers: missing site specificity and absent documentation of the injected substance.
See how Mira captures CPT 20615 documentation